SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The problems with today's pharmaceutical business—an outsider's view
0 references·7 citing·19 second hop
The problems with today's pharmaceutical business—an outsider's view (2011)The problems with today's pharmaceutical …R&D efficiency of leading pharmaceutical companies – A 20-year analysis (2021)R&D efficiency of leading pha…Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization (2020)Evolving Outsourcing Landscap…The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry (2019)The importance of geographica…The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance (2017)The moderating role of absorp…Opening the door to innovation (2014)Opening the door to innovationThe changing face of corporate venturing in biotechnology (2012)The changing face of corporat…Biosimilars: Company Strategies to Capture Value from the Biologics Market (2012)Biosimilars: Company Strategi…What's fueling the biotech engine? (2007)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Towards understanding who makes corporate venture capital investments and why (2009)Entrepreneurial finance meets organizational reality: comparing investment practices and performance of corporate and independent venture capitalists (2010)The importance of new companies for drug discovery: origins of a decade of new drugs (2010)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Firm Resources and Sustained Competitive Advantage (1991)Firm resources and sustained competitive advantage (2004)Direct and indirect effects of degree of interdisciplinarity on firms' innovation performance: The moderating role of firms' capabilities (2024)Exploration and Exploitation in Organizational Learning (1991)Knowledge of the Firm, Combinative Capabilities, and the Replication of Technology (1992)Evolution of the collaborative innovation network in the Korean ICT industry: a patent-based analysis (2021)Whither geographic proximity? Bypassing local R&D units in foreign university collaboration (2021)Collaborative innovation during the drug discovery and development process (2025)Reproducibility in Science (2014)Can the pharmaceutical industry reduce attrition rates? (2004)Clinical development success rates for investigational drugs (2014)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2012Biosimilars: Company Strategies to Capture Value from the Biologics Market89 cited
  • 2021R&D efficiency of leading pharmaceutical companies – A 20-year analysis54 cited
  • 2017The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance42 cited
  • 2019The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry36 cited
  • 2020Evolving Outsourcing Landscape in Pharma R&D: Different Collaborative Models and Factors To Consider When Choosing a Contract Research Organization18 cited
  • 2012The changing face of corporate venturing in biotechnology16 cited
  • 2014Opening the door to innovation15 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work